Phialogics
About:
Phialogics is focuses on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.
Website: https://www.phialogics.com/
Top Investors: HTGF | High-Tech Gruenderfonds, BaseLaunch
Description:
Phialogics is a preclinical biotech business with a focus on developing next-generation biologics to balance the immune response in both acute and long-term inflammation.
Total Funding Amount:
$1.21M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Allschwil, Basel-Landschaft, Switzerland
Founded Date:
2021-01-01
Contact Email:
ernst(AT)phialogics.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-10-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai